Next Science Limited announced an update on the FDA approval process in relation to its XPerience Surgical Rinse. Next Science has received written notification from the FDA of additional requirements to obtain a 510(k) Class II clearance for XPerience. To demonstrate substantial equivalence, the FDA requires Next Science to undertake a further animal study and a further laboratory test. Having anticipated these requirements, Next Science has already set the additional study and test in motion and expects they will be completed in time to enable it to lodge a 510(k) Class II FDA submission in November 2020, setting the expected timing for the US launch of XPerience to H1 2021. This timing is consistent with communication to the market on 26 August 2020 when released half year results.